Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Correction

This article was originally published in The Tan Sheet

Executive Summary

An April 10 story in "The Tan Sheet" about the "U.S. & EU Comparative Case Study: Functional Foods & Supplements" workshop held in Washington, D.C. April 4 omitted the mention of the other two cosponsors of the event 1("The Tan Sheet" April 10, 2006, p. 9). In addition to French firm Coutrelis & Associes, the workshop was co-sponsored by firms Hyman, Phelps & McNamara (Washington, D.C.) and Cantox Health Sciences International (Ontario, Canada)...

You may also be interested in...



EU Policy Would Harmonize Health Claims, Grant Proprietary Rights – Lawyer

A directive that is under consideration by the European Union to harmonize health claims across member states would grant proprietary rights to claims that are substantiated by original research, according to Attorney Nicole Coutrelis

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099279

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel